Penardo Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.85 M
as on 15-11-2024
- Satisfied Charges ₹ 6.50 M
as on 15-11-2024
- Revenue -19.25%
(FY 2023)
- Profit -9.73%
(FY 2023)
- Ebitda 0.45%
(FY 2023)
- Net Worth 21.27%
(FY 2023)
- Total Assets 65.59%
(FY 2023)
About Penardo Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.85 M. The company has closed loans amounting to ₹6.50 M, as per Ministry of Corporate Affairs (MCA) records.
Mukesh Kapoor, Akshay Kapoor, and Anil Kapoor serve as directors at the Company.
- CIN/LLPIN
U74999HR2017PTC070117
- Company No.
070117
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jul 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Ambala, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Penardo Biotech Private Limited offer?
Penardo Biotech Private Limited offers a wide range of products and services, including Third Party Manufacturing Consultancy, Pharmaceutical Third Party Manufacturing, Pharma Franchise, PCD Pharma Franchise, Pharmaceutical Distributors, Injectable Products, Pharmaceutical Injectables.
Who are the key members and board of directors at Penardo Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Kapoor  | Director | 17-Jul-2019 | Current |
| Akshay Kapoor | Director | 20-Jul-2022 | Current |
| Anil Kapoor | Director | 28-Jul-2017 | Current |
Financial Performance of Penardo Biotech.
Penardo Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.25% decrease. The company also saw a slight decrease in profitability, with a 9.73% decrease in profit. The company's net worth Soared by an impressive increase of 21.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Penardo Biotech?
In 2023, Penardo Biotech had a promoter holding of 82.50% and a public holding of 17.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 May 2023 | ₹6.70 M | Open |
Hdfc Bank Limited Creation Date: 19 Jan 2021 | ₹1.15 M | Open |
Axis Bank Limited Creation Date: 25 Mar 2021 | ₹6.50 M | Satisfied |
How Many Employees Work at Penardo Biotech?
Unlock and access historical data on people associated with Penardo Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Penardo Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Penardo Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
